Reference - Detail
| RRC ID | 46062 |
|---|---|
| Author | Liachko NF, McMillan PJ, Guthrie CR, Bird TD, Leverenz JB, Kraemer BC. |
| Title | CDC7 inhibition blocks pathological TDP-43 phosphorylation and neurodegeneration. |
| Journal | Ann Neurol |
| Abstract |
OBJECTIVE:Kinase hyperactivity occurs in both neurodegenerative disease and cancer. Lesions containing hyperphosphorylated aggregated TDP-43 characterize amyotrophic lateral sclerosis and frontotemporal lobar degeneration with TDP-43 inclusions. Dual phosphorylation of TDP-43 at serines 409/410 (S409/410) drives neurotoxicity in disease models; therefore, TDP-43-specific kinases are candidate targets for intervention. METHODS:To find therapeutic targets for the prevention of TDP-43 phosphorylation, we assembled and screened a comprehensive RNA interference library targeting kinases in TDP-43 transgenic Caenorhabditis elegans. RESULTS:We show CDC7 robustly phosphorylates TDP-43 at pathological residues S409/410 in C. elegans, in vitro, and in human cell culture. In frontotemporal lobar degeneration (FTLD)-TDP cases, CDC7 immunostaining overlaps with the phospho-TDP-43 pathology found in frontal cortex. Furthermore, PHA767491, a small molecule inhibitor of CDC7, reduces TDP-43 phosphorylation and prevents TDP-43-dependent neurodegeneration in TDP-43-transgenic animals. INTERPRETATION:Taken together, these data support CDC7 as a novel therapeutic target for TDP-43 proteinopathies, including FTLD-TDP and amyotrophic lateral sclerosis. |
| Volume | 74(1) |
| Pages | 39-52 |
| Published | 2013-7-1 |
| DOI | 10.1002/ana.23870 |
| PMID | 23424178 |
| PMC | PMC3775949 |
| MeSH | Animals Animals, Genetically Modified Caenorhabditis elegans Caenorhabditis elegans Proteins / genetics Cell Cycle Proteins / metabolism* Cell Line, Transformed DNA-Binding Proteins / metabolism* Disease Models, Animal Enzyme Inhibitors / pharmacology Frontal Lobe / metabolism Frontal Lobe / pathology Gene Expression Regulation / drug effects Gene Expression Regulation / genetics Humans Movement / physiology Mutation / genetics Neurodegenerative Diseases / drug therapy Neurodegenerative Diseases / etiology* Neurodegenerative Diseases / genetics Neurodegenerative Diseases / pathology Phosphorylation Piperidones / pharmacology Protein Serine-Threonine Kinases / metabolism* Pyrroles / pharmacology RNA, Small Interfering / genetics RNA, Small Interfering / metabolism Serine / metabolism TDP-43 Proteinopathies / complications TDP-43 Proteinopathies / drug therapy TDP-43 Proteinopathies / genetics TDP-43 Proteinopathies / therapy* Transfection |
| IF | 9.037 |
| Times Cited | 45 |
| WOS Category | CLINICAL NEUROLOGY NEUROSCIENCES |
| Altmetric score |
オルトメトリクス指標項目
|
| The most frequently cited source | X(Twitter) |
| Total number of mentions | 10 |
| Altmetric score changes over past 6months | 0.0 |
| Resource | |
| C.elegans | tm4189 tm4127 tm3933 tm4845 tm4391 tm4516 |